TG Therapeutics Files 8-K: Operations & Financials
Ticker: TGTX · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1001316
Sentiment: neutral
Topics: 8-K, financials, operations
Related Tickers: TGTX
TL;DR
TG Therapeutics filed an 8-K on Aug 4, 2025, reporting on operations and financials.
AI Summary
On August 4, 2025, TG Therapeutics, Inc. filed an 8-K report detailing results of operations and financial condition, along with financial statements and exhibits. The filing does not contain specific financial figures or operational updates within the provided text, but indicates a standard reporting event.
Why It Matters
This filing serves as a standard disclosure for TG Therapeutics, Inc., providing investors with updates on the company's operational and financial status as required by the SEC.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for reporting operational and financial information, with no immediate negative or positive indicators presented in the provided text.
Key Players & Entities
- TG Therapeutics, Inc. (company) — Registrant
- August 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 36-3898269 (identifier) — IRS Employer Identification No.
- 3020 Carrington Mill Blvd , Suite 475 Morrisville , North Carolina (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing by TG Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed or effective?
The report was filed as of August 4, 2025, and the date of the earliest event reported is also August 4, 2025.
In which U.S. state is TG Therapeutics, Inc. incorporated?
TG Therapeutics, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number (EIN) for TG Therapeutics, Inc.?
The IRS Employer Identification Number for TG Therapeutics, Inc. is 36-3898269.
What is the business address listed for TG Therapeutics, Inc.?
The business address listed is 3020 Carrington Mill Blvd, Suite 475, Morrisville, North Carolina.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding TG THERAPEUTICS, INC. (TGTX).